The progression of Parkinson's disease often requires a change of therapy. An expert explains when this should be done and ...

Growing older is the greatest risk factor for acquiring Parkinson’s disease and many people live with symptoms for several years before being diagnosed. Often people in early stages of Parkinson’s ...

Centogene NV and ROPAD consortium publish data from a landmark study identifying genetic variants that may respond to ...

The company plans to submit a new drug application for tavapadon to the US Food and Drug Administration next year.

"Using these findings, we could identify individuals with specific deficiencies and administer oral riboflavin and biotin ...

AbbVie's experimental drug to treat early Parkinson's disease met the main goal in a late-stage study, the drugmaker said on ...

Intra-Cellular Therapies is developing Lenrispodun for the treatment of patients with Parkinson's Disease in a phase 2 study.

Two teams of scientists have recently come up with potential breakthroughs with preventing a serious side effect of Parkinson ...

A decline in motor skills is a hallmark of Parkinson's disease, regularly taking the form of slowness, rigidity, and tremors.

Treatment with tavapadon led to a statistically significant improvement in motor function compared with placebo. Topline results were announced from a phase 3 trial evaluating tavapadon, a selective ...

Critically, they find that immune challenge is ... A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating ...

Researchers at the Foundation have uncovered new insights into the complex link between dopamine and rest tremor in Parkinson ...